Comprehensive analysis of the HIV/AIDS policy-making process in Iran.


Journal

Health research policy and systems
ISSN: 1478-4505
Titre abrégé: Health Res Policy Syst
Pays: England
ID NLM: 101170481

Informations de publication

Date de publication:
19 Jul 2019
Historique:
received: 07 10 2018
accepted: 06 06 2019
entrez: 21 7 2019
pubmed: 22 7 2019
medline: 30 1 2020
Statut: epublish

Résumé

A huge number of people living with HIV/AIDS lives in developing countries. Thus, strengthening health systems in these countries is a prerequisite for improving disease prevention and care. After three decades of HIV/AIDS policy-making in Iran, conducting a comprehensive analysis on the policy process seems to be essential. In the present study, we aimed to analyse the HIV/AIDS policy-making process in Iran from 1986 to 2016. This was a theory-based, multi-method and retrospective study. Interviewing of key informants and review of policy documents were concurrently conducted to identify and include further key informants (39 participants) and documents in the study. Framework analysis was used to analyse data. The mean age of participants working in HIV/AIDS policy-making was of 48 years and participants had a mean of 14 years of working experience. Findings were categorized as contextual factors, content of HIV/AIDS policies, actors involved in the policy process, and evidence use in the policy process. Contextual effective factors on the HIV/AIDS policy-making process were categorized into five major themes, namely situational factors, structural-managerial factors, socioeconomic factors, political and legal factors, and international factors. The HIV/AIDS phenomenon in Iran was identified to be deeply rooted in the culture and traditions of society. The HIV/AIDS policy content has, recently, been crystallized in the national strategic plans and harm reduction policies of the country. The policy process has been conducted with a solely governmental top-down approach and is now suffering from poor evidence and lack of sufficient consideration of contextual factors. There is a great need for change in the approach of government towards the issue and to increase the participation of non-governmental sectors and civil society in the policy process.

Sections du résumé

BACKGROUND BACKGROUND
A huge number of people living with HIV/AIDS lives in developing countries. Thus, strengthening health systems in these countries is a prerequisite for improving disease prevention and care. After three decades of HIV/AIDS policy-making in Iran, conducting a comprehensive analysis on the policy process seems to be essential. In the present study, we aimed to analyse the HIV/AIDS policy-making process in Iran from 1986 to 2016.
METHODS METHODS
This was a theory-based, multi-method and retrospective study. Interviewing of key informants and review of policy documents were concurrently conducted to identify and include further key informants (39 participants) and documents in the study. Framework analysis was used to analyse data.
RESULTS RESULTS
The mean age of participants working in HIV/AIDS policy-making was of 48 years and participants had a mean of 14 years of working experience. Findings were categorized as contextual factors, content of HIV/AIDS policies, actors involved in the policy process, and evidence use in the policy process. Contextual effective factors on the HIV/AIDS policy-making process were categorized into five major themes, namely situational factors, structural-managerial factors, socioeconomic factors, political and legal factors, and international factors. The HIV/AIDS phenomenon in Iran was identified to be deeply rooted in the culture and traditions of society. The HIV/AIDS policy content has, recently, been crystallized in the national strategic plans and harm reduction policies of the country. The policy process has been conducted with a solely governmental top-down approach and is now suffering from poor evidence and lack of sufficient consideration of contextual factors.
CONCLUSIONS CONCLUSIONS
There is a great need for change in the approach of government towards the issue and to increase the participation of non-governmental sectors and civil society in the policy process.

Identifiants

pubmed: 31324185
doi: 10.1186/s12961-019-0466-6
pii: 10.1186/s12961-019-0466-6
pmc: PMC6642503
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69

Subventions

Organisme : Tehran University of Medical Sciences and Health Services
ID : -

Références

Int J Health Plann Manage. 2003 Oct-Dec;18 Suppl 1:S41-51
pubmed: 14661940
BMC Med Res Methodol. 2009 Aug 11;9:59
pubmed: 19671152
Health Policy Plan. 2010 May;25(3):171-85
pubmed: 19955092
East Mediterr Health J. 2010 Mar;16(3):259-65
pubmed: 20795438
Glob Health Action. 2010 Aug 28;3:null
pubmed: 20824159
Health Policy. 2011 May;100(2-3):167-73
pubmed: 21194780
Int J Drug Policy. 2012 Jul;23(4):319-26
pubmed: 22206713
Health Res Policy Syst. 2013 Feb 23;11(1):7
pubmed: 23433339
J Adv Nurs. 2013 Nov;69(11):2423-31
pubmed: 23517523
Iran J Public Health. 2013 May 01;42(5):540-1
pubmed: 23802115
AIDS Behav. 2014 Jan;18 Suppl 1:S19-24
pubmed: 23857356
Iran J Public Health. 2013 Jan 01;42(Supple1):42-9
pubmed: 23865015
Asian Pac J Trop Biomed. 2014 Jan;4(1):65-8
pubmed: 24144133
Int J Drug Policy. 2014 Jul;25(4):717-23
pubmed: 24974367
Sex Health. 2014 Dec;11(6):568-74
pubmed: 25419677
Iran J Public Health. 2014 Apr;43(4):471-9
pubmed: 26005657
Iran J Public Health. 2014 Oct;43(10):1424-35
pubmed: 26060705
Int J High Risk Behav Addict. 2015 Dec 01;4(4):e22863
pubmed: 26870709
Int J Infect Dis. 2016 Mar;44:66-73
pubmed: 26948920
Int J Drug Policy. 2016 May;31:184-9
pubmed: 27012581
Iran J Public Health. 2016 Jan;45(1):109-11
pubmed: 27057532
Int J Drug Policy. 2016 Jun;32:64-9
pubmed: 27157980
Int J Adolesc Med Health. 2016 May 13;30(1):null
pubmed: 27176740
J Int AIDS Soc. 2016 May 27;19(1):20873
pubmed: 27237131
Clin Infect Dis. 2016 Sep 15;63(6):846
pubmed: 27282708
Med J Islam Repub Iran. 2016 Jul 03;30:392
pubmed: 27579283
Sex Transm Infect. 2017 Sep;93(6):421-423
pubmed: 27601728
PLoS One. 2016 Sep 14;11(9):e0161849
pubmed: 27626638
AIDS Behav. 2017 Jul;21(Suppl 1):5-14
pubmed: 28124296
Implement Sci. 2017 Apr 5;12(1):47
pubmed: 28381264
Addict Health. 2016 Jul;8(3):136-144
pubmed: 28496952
Addict Health. 2016 Jul;8(3):186-194
pubmed: 28496957
Health Policy Plan. 2017 Nov 1;32(9):1316-1326
pubmed: 28981667
Indian J Sex Transm Dis AIDS. 2017 Jul-Dec;38(2):157-162
pubmed: 30148270
Health Res Policy Syst. 2018 Sep 21;16(1):92
pubmed: 30241489
PLoS One. 2018 Nov 29;13(11):e0207681
pubmed: 30496204
AIDS Behav. 2019 Jun;23(6):1590-1593
pubmed: 30734211

Auteurs

Rahim Khodayari-Zarnaq (R)

Iranian Center of Excellence in Health Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.

Ali Mohammad Mosaddeghrad (AM)

Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Haidar Nadrian (H)

Social Determinants of Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Neda Kabiri (N)

Iranian Center of Excellence in Health Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.

Hamid Ravaghi (H)

Department of Health Services Management, Iran University of medical sciences, Tehran, Iran. ravaghi.h@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH